Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

Cancer Cell - Tập 41 - Trang 1091-1102.e4 - 2023
Mark Jesus M. Magbanua1, Lamorna Brown Swigart1, Ziad Ahmed1, Rosalyn W. Sayaman1, Derrick Renner2, Ekaterina Kalashnikova2, Gillian L. Hirst1, Christina Yau1, Denise M. Wolf1, Wen Li1, Amy L. Delson3, Smita Asare4, Minetta C. Liu2,5, Kathy Albain6, A. Jo Chien1, Andres Forero-Torres7, Claudine Isaacs8, Rita Nanda9, Debu Tripathy10, Angel Rodriguez2
1University of California, San Francisco, San Francisco, CA 94143 USA
2Natera, Inc., Austin, TX 78753, USA
3UCSF Breast Science Advocacy Core, San Francisco, CA 94143, USA
4Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA
5Mayo Clinic, Rochester, MN 55905 USA
6Loyola University Chicago, Maywood, IL 60153, USA
7University of Alabama at Birmingham, Birmingham, AL 35233, USA
8Georgetown University, Washington, DC 20007, USA
9University of Chicago, Chicago, IL, 60637, USA
10University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Cancer Cell

Tập 41

1091-1102.e4

Thông tin tác giả